If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nives Carenini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Platinum Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Cells Chemical Compounds
Drug Combinations Medicine & Life Sciences
Pharmaceutical Preparations Chemical Compounds
MicroRNAs Chemical Compounds
Modulation Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

Axl downstream targeting unravels synergistic drug combinations in ovarian carcinoma cells

Alampi, D. M., Ciusani, E., Carenini, N., Corna, E., Gatti, L. & Corno, C., Jan 1 2019, In : Anticancer Research. 39, 7, p. 3803-3808 6 p.

Research output: Contribution to journalArticle

Drug Combinations
Receptor Protein-Tyrosine Kinases
STAT3 Transcription Factor

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models

Corno, C., Stucchi, S., De Cesare, M., Carenini, N., Stamatakos, S., Ciusani, E., Minoli, L., Scanziani, E., Argueta, C., Landesman, Y., Zaffaroni, N., Gatti, L. & Perego, P., 2018, In : Biochemical Pharmacology. 147, p. 93-103 11 p.

Research output: Contribution to journalArticle

Pharmaceutical Preparations

PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells

Arrighetti, N., Cossa, G., De Cecco, L., Stucchi, S., Carenini, N., Corna, E., Gandellini, P., Zaffaroni, N., Perego, P. & Gatti, L., Nov 1 2016, In : Toxicology and Applied Pharmacology. 310, p. 9-19 11 p.

Research output: Contribution to journalArticle

Platinum Compounds